Kaempferol induced apoptosis via endoplasmic reticulum stress and mitochondria-dependent pathway in human osteosarcoma U-2 OS cells. 2010

Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.

Kaempferol is a natural flavonoid. Previous studies have reported that kaempferol has anti-proliferation activities and induces apoptosis in many cancer cell lines. However, there are no reports on human osteosarcoma. In this study, we investigate the anti-cancer effects and molecular mechanisms of kaempferol in human osteosarcoma cells. Our results demonstrate that kaempferol significantly reduces cell viabilities of U-2 OS, HOB and 143B cells, especially U-2 OS cells in a dose-dependent manner, but exerts low cytotoxicity on human fetal osteoblast progenitor hFOB cells. Comet assay, DAPI staining and DNA gel electrophoresis confirm the effects of DNA damage and apoptosis in U-2 OS cells. Flow cytometry detects the increase of cytoplasmic Ca(2+) levels and the decrease of mitochondria membrane potential. Western blotting and fluorogenic enzymatic assay show that kaempferol treatment influences the time-dependent expression of proteins involved in the endoplasmic reticulum stress pathway and mitochondrial signaling pathway. In addition, pretreating cells with caspase inhibitors, BAPTA or calpeptin before exposure to kaempferol increases cell viabilities. The anti-cancer effects of kaempferol in vivo are evaluated in BALB/c(nu/nu) mice inoculated with U-2 OS cells, and the results indicate inhibition of tumor growth. In conclusion, kaempferol inhibits human osteosarcoma cells in vivo and in vitro.

UI MeSH Term Description Entries
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D001859 Bone Neoplasms Tumors or cancer located in bone tissue or specific BONES. Bone Cancer,Cancer of Bone,Cancer of the Bone,Neoplasms, Bone,Bone Neoplasm,Neoplasm, Bone
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004721 Endoplasmic Reticulum A system of cisternae in the CYTOPLASM of many cells. In places the endoplasmic reticulum is continuous with the plasma membrane (CELL MEMBRANE) or outer membrane of the nuclear envelope. If the outer surfaces of the endoplasmic reticulum membranes are coated with ribosomes, the endoplasmic reticulum is said to be rough-surfaced (ENDOPLASMIC RETICULUM, ROUGH); otherwise it is said to be smooth-surfaced (ENDOPLASMIC RETICULUM, SMOOTH). (King & Stansfield, A Dictionary of Genetics, 4th ed) Ergastoplasm,Reticulum, Endoplasmic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012516 Osteosarcoma A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed) Sarcoma, Osteogenic,Osteogenic Sarcoma,Osteosarcoma Tumor,Osteogenic Sarcomas,Osteosarcoma Tumors,Osteosarcomas,Sarcomas, Osteogenic,Tumor, Osteosarcoma,Tumors, Osteosarcoma
D015398 Signal Transduction The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway. Cell Signaling,Receptor-Mediated Signal Transduction,Signal Pathways,Receptor Mediated Signal Transduction,Signal Transduction Pathways,Signal Transduction Systems,Pathway, Signal,Pathway, Signal Transduction,Pathways, Signal,Pathways, Signal Transduction,Receptor-Mediated Signal Transductions,Signal Pathway,Signal Transduction Pathway,Signal Transduction System,Signal Transduction, Receptor-Mediated,Signal Transductions,Signal Transductions, Receptor-Mediated,System, Signal Transduction,Systems, Signal Transduction,Transduction, Signal,Transductions, Signal

Related Publications

Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
March 2017, Molecules (Basel, Switzerland),
Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
December 2016, Oncology reports,
Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
July 2011, International journal of oncology,
Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
January 2015, International journal of clinical and experimental pathology,
Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
March 2016, Molecular medicine reports,
Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
November 2017, Molecular medicine reports,
Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
July 2017, Environmental toxicology,
Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
January 2021, Cell transplantation,
Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
January 2011, Journal of neuro-oncology,
Wen-Wen Huang, and Yu-Jen Chiu, and Ming-Jen Fan, and Hsu-Feng Lu, and Hsiu-Feng Yeh, and Kun-Hong Li, and Po-Yuan Chen, and Jing-Gung Chung, and Jai-Sing Yang
December 2002, Chinese medical journal,
Copied contents to your clipboard!